## **Core Concept**
Anaesthesia in hypotensive patients requires careful selection of drugs to avoid further decreasing blood pressure. The primary goal is to choose agents that maintain cardiovascular stability or have minimal depressant effects on the cardiovascular system.

## **Why the Correct Answer is Right**
The correct answer, **Etomidate**, is a short-acting intravenous anaesthetic agent known for its minimal impact on cardiovascular stability. It works by enhancing the effect of GABA (gamma-aminobutyric acid) at the GABA_A receptor, leading to sedation and hypnosis. Etomidate is particularly useful in patients with cardiovascular instability or hypotension because it does not significantly depress myocardial contractility or cause vasodilation, thus maintaining blood pressure.

## **Why Each Wrong Option is Incorrect**
- **Option A: Propofol** is a widely used anaesthetic induction agent that can cause significant hypotension due to vasodilation and depression of myocardial contractility, making it less ideal for hypotensive patients.
- **Option B: Ketamine** can increase blood pressure and heart rate due to its sympathomimetic effects, but it is not typically the first choice for maintaining anaesthesia in hypotensive patients due to its potential to increase myocardial oxygen demand.
- **Option D: Midazolam** is a benzodiazepine used for sedation and as an adjunct to anaesthesia. While it has a more favourable cardiovascular profile compared to some other anaesthetic agents, it is not specifically indicated for maintaining anaesthesia in hypotensive patients and can contribute to hypotension.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that etomidate is often the anaesthetic agent of choice in haemodynamically unstable patients, including those who are hypotensive, due to its minimal impact on cardiovascular function.

## **Correct Answer:** . **Etomidate**